NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Bipolar DepressionSuicidal Ideation

Interventions

DRUG

Ketamine Hydrochloride

Ketamine HCl will be infused intravenously at a dose of 0.5 mg/kg over 40 minutes

DRUG

Placebo

Normal Saline placebo will be infused IV over 40 minutes

Trial Locations (2)

Research Centers of America, Hollywood

JP Smith Hospital, Fort Worth